See Remarks
Joshua L. Smiley (also referred to as Smiley Joshua L) is the President and Chief Operating Officer of Zai Lab Ltd (ZLAB), a biopharmaceutical company focused on oncology, immunology, neuroscience, and infectious diseases.[[1]](https://www.zailaboratory.com/leadership/josh-smiley/)[[4]](https://www.hl.co.uk/shares/shares-search-results/z/zai-lab-ltd-ads-each-repr-10-ord-shares/company-information) He joined Zai Lab in August 2022 and oversees commercial operations, manufacturing, business development, finance, human resources, information technology, corporate affairs, and strategy.[[1]](https://www.zailaboratory.com/leadership/josh-smiley/)[[4]](https://www.hl.co.uk/shares/shares-search-results/z/zai-lab-ltd-ads-each-repr-10-ord-shares/company-information)
Prior to Zai Lab, Smiley spent over 25 years at Eli Lilly and Company, rising to Chief Financial Officer, with prior roles as senior vice president of finance, corporate controller, treasurer, and leader of U.S. sales, marketing, business development, and M&A.[[1]](https://www.zailaboratory.com/leadership/josh-smiley/)[[2]](https://www.gurufocus.com/insider/19739/joshua-l-smiley) He has engaged in recent insider trading at ZLAB, including a sale of 3,354 shares on April 4, 2025, and equity awards with sales for tax withholding on March 4, 2026, holding 91,026 ADSs afterward.[[2]](https://www.gurufocus.com/insider/19739/joshua-l-smiley)[[3]](https://www.stocktitan.net/sec-filings/ZLAB/form-4-zai-lab-ltd-insider-trading-activity-88471b67046e.html) Earlier, he served as SVP and CFO at Eli Lilly and director at Elanco Animal Health.[[2]](https://www.gurufocus.com/insider/19739/joshua-l-smiley)
View full insider profile →
